Marci L. Andrejko, NP

Marci Andrejko practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Marci Andrejko's NPI, 1417094491, was assigned on January 31, 2007. Marci Andrejko holds New York license 341446.

Marci Andrejko's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Marci Andrejko's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Hematology Lymphoma Group. Dmand AI also links Marci Andrejko to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Marci Andrejko practices. Vendor and product names are available with a free account.

Family is Marci Andrejko's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Marci Andrejko is licensed in New York.

CMS counts 57 Medicare patients who saw Marci Andrejko in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Marci Andrejko's median patient age at 69, with 53% women.

In 2024, Marci Andrejko wrote 78 Medicare Part D claims for 29 patients. 97% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Marci Andrejko for performance year 2024, reported as part of a group. Marci Andrejko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Marci Andrejko as offering telehealth.

CMS Open Payments shows 6 general payments to Marci Andrejko from 6 drug and device companies in 2025. Food and beverage make up the largest share, 90% of the total. Novocure Inc. paid the most, $213.